Company Profile

  1. You are here:    Home
  2. Search Databases
  3. Search Company Registry
  4. Company Profile

Nexilico Inc
Profile last edited on: 3/17/2020      CAGE: 7YGZ9      UEI: Z2H3SNX8WJ36

Business Identifier: Next generation computational tools for microbiome precision medicine
Year Founded
2017
First Award
2019
Latest Award
2022
Program Status
Active
Popularity Index

Edit Company Profile

Is this YOUR Company?
Ensure accuracy and completeness of YOUR Company Profile by completing the brief Survey Instrument attached
Do you know about this Awardees?
Let us encourage you to provide any data which would enhance the completeness of this firm's profile.
  Explanation Edit

Location Information

580 Ohlone Avenue
Albany, CA 94706
   (510) 409-1814
   N/A
   www.nexilico.inc
Location: Single
Congr. District: 12
County: Alameda

Public Profile

Nexilico Inc. is developing next generation computational tools for microbiome precision medicine.

Extent of SBIR involvement

User Avatar
Phase I Awards
3
Phase II Awards
0
Conversion Rate
0.00%
Phase I Dollars
$774,924
Phase II Dollars
$55,000
Total Awarded
$829,924

Synopsis: Awardee Business Condition

Employee Range
1-4
Revenue Range
Less than .5M
VC funded?
No
Public/Private
Privately Held
Stock Info
----
IP Holdings
N/A

Awards Distribution by Agency

Most Recent SBIR Projects
Year Phase Agency Total Amount
2023 2 NSF $1,224,995
Project Title: An omics-based computational platform for the personalization of gut microbiome therapeutics
2022 1 NIH $380,000
Project Title: Computational prediction of gut microbiome-mediated drug metabolism
2019 1 NIH $224,929
Project Title: A Predictive Computational Platform for Gut Microbiome Precision Medicine
0 1 NIH $275,765
Project Title: Novel probiotics to mitigate xenobiotic toxicity through microbial biotransformation

Key People / Management

  Mohammad Soheilypour

Company News

There are no news available.